LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 929 | 795 | 3216 | 0.2473 | -0.0835 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 72 | hr | 929 | 800 | 3216 | 0.2487 | -0.0805 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3069 | 3216 | 0.9542 | 0.9483 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3002 | 3216 | 0.9333 | 0.9243 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3030 | 3216 | 0.9421 | 0.9342 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 2985 | 3216 | 0.9281 | 0.9179 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 2740 | 3216 | 0.8516 | 0.8280 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 72 | hr | 929 | 736 | 3216 | 0.2290 | -0.1226 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 929 | 3169 | 3216 | 0.9851 | 0.9832 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 929 | 3131 | 3216 | 0.9736 | 0.9703 |
Hs 578T | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 929 | 3112 | 3216 | 0.9674 | 0.9629 |
Hs 578T | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 929 | 2990 | 3216 | 0.9293 | 0.9193 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 929 | 3087 | 3216 | 0.9598 | 0.9545 |
Hs 578T | GSK1904529A | 10 | uM | LJP6 | 72 | hr | 929 | 3070 | 3216 | 0.9546 | 0.9487 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3174 | 3237 | 0.9805 | 0.9783 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3137 | 3237 | 0.9691 | 0.9654 |
Hs 578T | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2995 | 3237 | 0.9253 | 0.9156 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 929 | 3128 | 3237 | 0.9663 | 0.9622 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 3132 | 3237 | 0.9674 | 0.9634 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 72 | hr | 929 | 2646 | 3237 | 0.8174 | 0.7881 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3198 | 3237 | 0.9880 | 0.9867 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 929 | 3239 | 3237 | 1.0005 | 1.0006 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3162 | 3237 | 0.9770 | 0.9743 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 929 | 3092 | 3237 | 0.9552 | 0.9497 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 2948 | 3237 | 0.9109 | 0.8990 |